Fluorodeoxyglucose F18

"Fluorodeoxyglucose F18" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the assessment of cerebral and myocardial glucose metabolism in various physiological or pathological states including stroke and myocardial ischemia. It is also employed for the detection of malignant tumors including those of the brain, liver, and thyroid gland. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1162)

Descriptor ID	D019788
MeSH Number(s)	D09.254.229.500
Concept/Terms	Fluorodeoxyglucose F18 Fluorodeoxyglucose F18 F18, Fluorodeoxyglucose 18F-FDG Fluorodeoxyglucose F 18 F 18, Fluorodeoxyglucose Fludeoxyglucose F 18 F 18, Fludeoxyglucose Fluorine-18-fluorodeoxyglucose Fluorine 18 fluorodeoxyglucose 18F Fluorodeoxyglucose Fluorodeoxyglucose, 18F 18FDG 2-Fluoro-2-deoxy-D-glucose 2-Fluoro-2-deoxy-D-glucose 2 Fluoro 2 deoxy D glucose 2-Fluoro-2-deoxyglucose 2 Fluoro 2 deoxyglucose

Below are MeSH descriptors whose meaning is more general than "Fluorodeoxyglucose F18".

Chemicals and Drugs [D]
Carbohydrates [D09]
Deoxy Sugars [D09.254]
Deoxyglucose [D09.254.229]
Fluorodeoxyglucose F18 [D09.254.229.500]

Below are MeSH descriptors whose meaning is related to "Fluorodeoxyglucose F18".

Below are MeSH descriptors whose meaning is more specific than "Fluorodeoxyglucose F18".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Fluorodeoxyglucose F18" by people in this website by year, and whether "Fluorodeoxyglucose F18" was a major or minor topic of these publications.

Bar chart showing 65 publications over 25 distinct years, with a maximum of 6 publications in 2011 and 2012

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1997	0	1	1
2000	1	0	1
2001	1	0	1
2002	1	1	2
2004	2	0	2
2005	0	1	1
2006	0	2	2
2007	3	1	4
2008	3	1	4
2009	1	1	2
2010	1	2	3
2011	3	3	6
2012	1	5	6
2013	3	2	5
2014	3	1	4
2015	0	1	1
2016	2	3	5
2017	2	1	3
2018	0	1	1
2020	1	0	1
2021	2	1	3
2022	0	1	1
2023	0	1	1
2024	3	1	4

Below are the most recent publications written about "Fluorodeoxyglucose F18" by people in Profiles.

Bourque JM, Birgersdotter-Green U, Bravo PE, Budde RPJ, Chen W, Chu VH, Dilsizian V, Erba PA, Gallegos Kattan C, Habib G, Hyafil F, Khor YM, Manlucu J, Mason PK, Miller EJ, Moon MR, Parker MW, Pettersson G, Schaller RD, Slart RHJA, Strom JB, Wilkoff BL, Williams A, Woolley AE, Zwischenberger BA, Dorbala S. 18F-FDG PET/CT and Radiolabeled Leukocyte SPECT/CT Imaging for the Evaluation of Cardiovascular Infection in the Multimodality Context: ASNC Imaging Indications (ASNC I2) Series Expert Consensus Recommendations From ASNC, AATS, ACC, AHA, ASE, EANM, HRS, IDSA, SCCT, SNMMI, and STS. JACC Cardiovasc Imaging. 2024 Jun; 17(6):669-701.

View in: PubMed
Bourque JM, Birgersdotter-Green U, Bravo PE, Budde RPJ, Chen W, Chu VH, Dilsizian V, Erba PA, Gallegos Kattan C, Habib G, Hyafil F, Khor YM, Manlucu J, Mason PK, Miller EJ, Moon MR, Parker MW, Pettersson G, Schaller RD, Slart RHJA, Strom JB, Wilkoff BL, Williams A, Woolley AE, Zwischenberger BA, Dorbala S. 18F-FDG PET/CT and radiolabeled leukocyte SPECT/CT imaging for the evaluation of cardiovascular infection in the multimodality context: ASNC Imaging Indications (ASNC I2) Series Expert Consensus Recommendations from ASNC, AATS, ACC, AHA, ASE, EANM, HRS, IDSA, SCCT, SNMMI, and STS. J Nucl Cardiol. 2024 Apr; 34:101786.

View in: PubMed
Bourque JM, Birgersdotter-Green U, Bravo PE, Budde RPJ, Chen W, Chu VH, Dilsizian V, Erba PA, Gallegos Kattan C, Habib G, Hyafil F, Khor YM, Manlucu J, Mason PK, Miller EJ, Moon MR, Parker MW, Pettersson G, Schaller RD, Slart RHJA, Strom JB, Wilkoff BL, Williams A, Woolley AE, Zwischenberger BA, Dorbala S. 18F-FDG PET/CT and radiolabeled leukocyte SPECT/CT imaging for the evaluation of cardiovascular infection in the multimodality context: ASNC Imaging Indications (ASNC I2) Series Expert Consensus Recommendations from ASNC, AATS, ACC, AHA, ASE, EANM, HRS, IDSA, SCCT, SNMMI, and STS. Heart Rhythm. 2024 05; 21(5):e1-e29.

View in: PubMed
Azimi M, Kamali-Asl A, Ay MR, Zeraatkar N, Hosseini MS, Sanaat A, Arabi H. Attention-based deep neural network for partial volume correction in brain 18F-FDG PET imaging. Phys Med. 2024 Mar; 119:103315.

View in: PubMed
Chang KJ, Kim DH, Lalani TK, Paroder V, Pickhardt PJ, Shaish H, Bates DDB. Radiologic T staging of colon cancer: renewed interest for clinical practice. Abdom Radiol (NY). 2023 09; 48(9):2874-2887.

View in: PubMed
Hanson J, Kreitman K, Baidoo L. Incidental Finding During Colonoscopy. Gastroenterology. 2022 11; 163(5):e27-e28.

View in: PubMed
Zuo Y, L?pez JE, Smith TW, Foster CC, Carson RE, Badawi RD, Wang G. Multiparametric cardiac18F-FDG PET in humans: pilot comparison of FDG delivery rate with82Rb myocardial blood flow. Phys Med Biol. 2021 07 30; 66(15).

View in: PubMed
McIntosh LJ, Rosen MP, Mittal K, Whalen GF, Bathini VG, Ali T, Edmiston KL, Walsh WV, Gerber JM. Coordination and optimization of FDG PET/CT and COVID-19 vaccination; Lessons learned in the early stages of mass vaccination. Cancer Treat Rev. 2021 Jul; 98:102220.

View in: PubMed
McIntosh LJ, Bankier AA, Vijayaraghavan GR, Licho R, Rosen MP. COVID-19 Vaccination-Related Uptake on FDG PET/CT: An Emerging Dilemma and Suggestions for Management. AJR Am J Roentgenol. 2021 10; 217(4):975-983.

View in: PubMed
Vos EL, Grewal RK, Russo AE, Reidy-Lagunes D, Untch BR, Gavane SC, Boucai L, Geer E, Gopalan A, Chou JF, Capanu M, Strong VE. Predicting malignancy in patients with adrenal tumors using 18 F-FDG-PET/CT SUVmax. J Surg Oncol. 2020 Dec; 122(8):1821-1826.

View in: PubMed

People

Explore

Similar Concepts

Top Journals